Seoul Pharmaceuticals exports impotency drugs to Azerbaijan
Seoul Pharmaceuticals exports impotency drugs to Azerbaijan
  • Lee Kap-soo
  • 승인 2019.06.26 12:34
  • 댓글 0
이 기사를 공유합니다

Seoul Pharmaceuticals will export Korean-made impotence treatment drugs to Azerbaijan in Eastern Europe. 

Seoul Pharmaceuticals said on June 26 that it has signed a contract with Azerbaijan's Loghman Pharm. to supply 10 milligrams and 20 milligrams of Tadalafil ODF, a film-type impotency drugs.

The contract period is five years, and the five-year expected exports amount to $1,284,600 (1.5 billion won), with licenses and trademark rights held by Seoul Pharmaceuticals. 

The Azerbaijan drug market stood at $700 million as of 2016, with imported drugs accounting for most of the market. Loghman Pharm. is a company that sells more than 80 products in Azerbaijan.

"The contract is meaningful in that products made with our technology will be the first to enter the Commonwealth of Independent States (CIS). As Azerbaijan's approval period is expected to take four months, we expect to obtain permission by the end of this year and make our first shipment of exports early next year," a Seoul Pharmaceuticals official said.

In 2012, Seoul Pharmaceuticals succeeded in commercializing its patented technology for manufacturing orally disintegrating film "smart film," which blocks bitter taste, and signed a contract to export film products to the Asia Pacific, China, Indonesia, the Middle East and Peru.


댓글삭제
삭제한 댓글은 다시 복구할 수 없습니다.
그래도 삭제하시겠습니까?
댓글 0
댓글쓰기
계정을 선택하시면 로그인·계정인증을 통해
댓글을 남기실 수 있습니다.

  • #1206, 36-4 Yeouido-dong, Yeongdeungpo-gu, Seoul, Korea(Postal Code 07331)
  • 서울특별시 영등포구 여의도동 36-4 (국제금융로8길 34) / 오륜빌딩 1206호
  • URL: www.koreaittimes.com / m.koreaittimes.com. Editorial Div. 02-578-0434 / 010-2442-9446. Email: info@koreaittimes.com.
  • Publisher: Monica Younsoo Chung. CEO: Lee Kap-soo. Editor: Jung Yeon-jin. Juvenile Protection Manager: Yeon Choul-woong.
  • IT Times Canada: Willow St. Vancouver BC, Canada / 070-7008-0005.
  • Copyright(C) Korea IT Times, Allrights reserved.
ND소프트